Unresectable Malignant Solid Neoplasm Suspended Phase 1 Trials for Olaparib (DB09074)
Indication | Status | Phase |
---|---|---|
DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Suspended | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT04585958 | Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer | Treatment |